Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 26, 2009

Mylan Reiterates and Stands Behind Its 48-Year Commitment and Track Record of Quality

Jul 26, 2009

Mylan Announces Issuance of Patent Covering EMSAM(R)

Jul 20, 2009

Mylan Declares Quarterly Preferred Stock Dividend

Jul 20, 2009

Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol

Jul 16, 2009

Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)

Jul 07, 2009

Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)

Jul 06, 2009

Mylan Schedules Second Quarter 2009 Financial Results Conference Call and Live Webcast

Jun 29, 2009

Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market

Jun 17, 2009

Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)

Jun 03, 2009

Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period

Pagination

First page
Previous page
…
Page 84
Page 85
Page 86
Page 87
Current page 88
Page 89
Page 90
Page 91
Page 92
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.